Rockwell Medical (RMTI) Competitors $1.14 -0.06 (-5.00%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.15 +0.01 (+0.88%) As of 03/28/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMDShould you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "health care equipment" industry. Rockwell Medical vs. ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed ReShape Lifesciences (NASDAQ:RSLS) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends. Is RSLS or RMTI more profitable? Rockwell Medical has a net margin of -1.25% compared to ReShape Lifesciences' net margin of -86.36%. Rockwell Medical's return on equity of 8.55% beat ReShape Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets ReShape Lifesciences-86.36% -179.83% -91.48% Rockwell Medical -1.25%8.55%3.80% Does the MarketBeat Community favor RSLS or RMTI? ReShape Lifesciences received 86 more outperform votes than Rockwell Medical when rated by MarketBeat users. Likewise, 66.11% of users gave ReShape Lifesciences an outperform vote while only 57.78% of users gave Rockwell Medical an outperform vote. CompanyUnderperformOutperformReShape LifesciencesOutperform Votes39866.11% Underperform Votes20433.89% Rockwell MedicalOutperform Votes31257.78% Underperform Votes22842.22% Which has more volatility and risk, RSLS or RMTI? ReShape Lifesciences has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Do analysts recommend RSLS or RMTI? Rockwell Medical has a consensus target price of $4.00, indicating a potential upside of 250.88%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts plainly believe Rockwell Medical is more favorable than ReShape Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReShape Lifesciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has preferable valuation & earnings, RSLS or RMTI? Rockwell Medical has higher revenue and earnings than ReShape Lifesciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReShape Lifesciences$8.18M0.16-$11.39MN/AN/ARockwell Medical$101.49M0.38-$8.44M-$0.02-57.00 Do institutionals & insiders have more ownership in RSLS or RMTI? 22.1% of ReShape Lifesciences shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 0.0% of ReShape Lifesciences shares are held by company insiders. Comparatively, 1.9% of Rockwell Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to RSLS or RMTI? In the previous week, Rockwell Medical had 11 more articles in the media than ReShape Lifesciences. MarketBeat recorded 13 mentions for Rockwell Medical and 2 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.43 beat Rockwell Medical's score of 0.13 indicating that ReShape Lifesciences is being referred to more favorably in the media. Company Overall Sentiment ReShape Lifesciences Positive Rockwell Medical Neutral SummaryRockwell Medical beats ReShape Lifesciences on 14 of the 17 factors compared between the two stocks. Remove Ads Get Rockwell Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMTI vs. The Competition Export to ExcelMetricRockwell MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.83M$6.90B$5.63B$7.84BDividend YieldN/A2.77%5.33%4.01%P/E Ratio-22.807.2623.5818.74Price / Sales0.38218.62388.2390.77Price / Cash92.7365.6738.1734.64Price / Book1.526.386.894.23Net Income-$8.44M$142.34M$3.20B$247.47M7 Day Performance-15.56%-5.15%-3.06%-2.29%1 Month Performance-31.74%-7.55%1.51%-5.81%1 Year Performance-31.33%-11.06%9.37%-0.96% Rockwell Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMTIRockwell Medical3.6541 of 5 stars$1.14-5.0%$4.00+250.9%-31.3%$38.83M$101.49M-22.80300Analyst RevisionRSLSReShape Lifesciences0.882 of 5 stars$0.64-3.2%N/A-96.4%$2.13M$8.18M0.0050Upcoming EarningsShort Interest ↓ABTAbbott Laboratories4.9229 of 5 stars$127.31+0.8%$137.94+8.4%+15.1%$220.79B$41.95B16.64115,000Options VolumeNews CoveragePositive NewsISRGIntuitive Surgical4.5954 of 5 stars$508.82+3.3%$611.86+20.2%+23.2%$181.23B$8.35B79.3812,100News CoveragePositive NewsBSXBoston Scientific4.2218 of 5 stars$102.74+2.0%$108.91+6.0%+45.0%$151.96B$16.75B82.1945,000News CoveragePositive NewsSYKStryker4.7603 of 5 stars$374.43+0.9%$421.90+12.7%+1.8%$142.87B$22.60B48.2553,000News CoveragePositive NewsMDTMedtronic4.3528 of 5 stars$90.16-0.2%$96.07+6.6%+0.5%$115.64B$33.20B27.4095,000News CoveragePositive NewsBDXBecton, Dickinson and Company4.7432 of 5 stars$229.10-0.5%$278.29+21.5%-8.1%$65.78B$20.64B38.0674,000Analyst DowngradeNews CoveragePositive NewsEWEdwards Lifesciences4.6138 of 5 stars$71.43+1.4%$79.95+11.9%-25.8%$41.99B$5.44B10.2517,300Insider TradeNews CoveragePositive NewsIDXXIDEXX Laboratories4.2534 of 5 stars$423.65+0.6%$533.75+26.0%-23.0%$34.34B$3.90B39.7110,800Analyst DowngradeNews CoveragePositive NewsRMDResMed4.5078 of 5 stars$222.95+1.5%$246.83+10.7%+11.0%$32.74B$4.93B26.328,160Analyst UpgradeNews CoveragePositive News Remove Ads Related Companies and Tools Related Companies ReShape Lifesciences Alternatives Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RMTI) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
